Heylmann, Daniel; Badura, Jennifer; Becker, Huong et al.
Sensitivity of CD3/CD28-stimulated versus non-stimulated lymphocytes to ionizing radiation and genotoxic anticancer drugs: key role of ATM in the differential radiation responseCELL DEATH & DISEASE. Bd. 9. 2018
Steigerwald, Christian; Rasenberger, Birgit; Christmann, Markus et al.
Sensitization of colorectal cancer cells to irinotecan by the Survivin inhibitor LLP3 depends on XAF1 proficiency in the context of mutated p53ARCHIVES OF TOXICOLOGY. Bd. 92. H. 8. 2018 S. 2645-2648
Steigerwald, C.; Rasenberger, B.; Kaina, B. et al.
Sensitization of colorectal cancer cells to topoisomerase I Inhibitors via pharmacological inhibition of IAPsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 391. 2018 S. S58-S58
Kaowinn, Sirichat; Kaewpiboon, Chutima; Koh, Sang Seok et al.
STAT1-HDAC4 signaling induces epithelial-mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2ONCOLOGY REPORTS. Bd. 40. H. 5. 2018 S. 2619-2627
Krämer, O; Mustafa, A.M.; Göder, A et al.
Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cellsOncotarget. Bd. 9. H. 45. 2018 S. 27835-27850
Wenz, Christine; Faust, Dagmar; Linz, Berenike et al.
t-BuOOH induces ferroptosis in human and murine cell linesARCHIVES OF TOXICOLOGY. Bd. 92. H. 2. 2018 S. 759-775
Tomicic, MT; Christmann, M
Targeting anticancer drug-induced senescence in glioblastoma therapyOncotarget. Bd. 9. H. 101. 2018 S. 37466 - 37467
Aasland, D.; Goetzinger, L.; Berte, N. et al.
Temozolomide induced senescence of glioma cells is activated in the G2 phase and associated with disruption of the E2F1/DP1 complex and repression of MMR and HRNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 391. 2018 S. S12-S12
Kiweler, Nicole; Brill, Boris; Wirth, Matthias et al.
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cellsARCHIVES OF TOXICOLOGY. Bd. 92. H. 7. 2018 S. 2227-2243
Roos, Wynand P.; Frohnapfel, Larissa; Quiros, Steve et al.
XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repairCANCER LETTERS. Bd. 424. 2018 S. 119-126